Federal grants to Regenerative Research Foundation
Regenerative Research Foundation in Albany, New York received $24.5 million in federal grants from fiscal 2021 to 2025, across 12 awards. Its largest program was Aging Research, with $14.4 million. In fiscal 2025 it was awarded $3.7 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$24.5 million
- Awards12
- Awarded in FY 2025$3.7 million
- Largest award$8.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 7 | $6.4 million |
| FY 2022 | 5 | $3.9 million |
| FY 2023 | 6 | $4.0 million |
| FY 2024 | 6 | $6.4 million |
| FY 2025 | 3 | $3.7 million |
Programs that fund Regenerative Research Foundation
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 5 | $14.4 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $4.2 million |
| Vision Research | 2 | $2.7 million |
| 21st Century Cures Act: Regenerative Medicine Initiative | 1 | $2.5 million |
| Biomedical Research and Research Training | 1 | $478,500 |
| Research Infrastructure Programs | 1 | $239,841 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 12 | $24.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Investigating the functional impact of ad risk genes on neuro-vascular interactions - project summary/abstract cerebrovascular pathology is present throughout stages of alzheimer’s disease and is correlated with cognitive changes. There is strong evidence that vascular dysfunction is a significant d | Aging Research | June 25, 2021 | $8.7 million |
| Defining characteristics of cortical progenitor cells over time in mouse and human | Extramural Research Programs in the Neurosciences and Neurological Disorders | December 4, 2020 | $2.6 million |
| PHASE1/2A clinical trial of rpesc-derived rpe transplantation as therapy for non-exudative age-related macular degeneration - project summary/abstract age-related macular degeneration (AMD) is a major cause of blindness in our aging population. Early amd pathogenesis involves atrophy of the retinal | 21st Century Cures Act: Regenerative Medicine Initiative | September 10, 2021 | $2.6 million |
| Characterizing human rpe cell proliferation to advance endogenous regeneration - project summary / abstract decades of study have demonstrated that adult human retinal pigment epithelium (RPE) cells have strong proliferative capacity in vitro, which indicates that the rpe layer has the possibility o | Vision Research | February 1, 2021 | $2.3 million |
| Cell type and regional vulnerability in frontotemporal dementia - project summary/abstract a key question in tauopathy research is why some brain cell populations are significantly affected while others are relatively spared. The long-term goal of this study is to understand this differential cell v | Aging Research | July 27, 2021 | $2.1 million |
| Human ipsc model of cerebro-vascular interactions in adrd - we propose to generate and validate a novel model that incorporates human cerebral cortical neurons and glia, vascular endothelial cells, neural crest pericytes and microglia from human induced pluripotent stem cells (IPSCS). The goal is a | Aging Research | August 15, 2024 | $1.9 million |
| Ipsc-based model to study frontotemporal dementia due to mapt mutation - our goal is to generate and validate a novel, cellularly complex model of frontotemporal dementia (FTD) due to mutations in the mapt gene that encodes tau (ftd-tau). The ninds 2022 adrd summit report describes the need for such | Extramural Research Programs in the Neurosciences and Neurological Disorders | May 30, 2025 | $1.5 million |
| Cell type and regional vulnerability in frontotemporal dementia - project summary/abstract a key question in tauopathy research is why some brain cell populations are significantly affected while others are relatively spared. The long-term goal of this study is to understand this differential cell v | Aging Research | August 12, 2024 | $1.3 million |
| Developing antibody-oligonucleotide bridges to simplify single cell spatial transcriptomics - project summary single cell rna-sequencing (scrna-seq) has enabled researchers to investigate a wide array of biological processes and how tissue heterogeneity contributes to function. These technologies ha | Biomedical Research and Research Training | February 22, 2022 | $478,500 |
| Characterization of human rpe subpopulations at the single cell level | Vision Research | June 8, 2021 | $412,250 |
Questions people ask
How much federal grant money does Regenerative Research Foundation get?
$24.5 million in 12 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Regenerative Research Foundation the most?
The Department of Health and Human Services, with $24.5 million in 12 awards.
What is Regenerative Research Foundation's largest federal grant?
$8.7 million under Aging Research, with its first action in the period on June 25, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Regenerative Research Foundation?
Its largest are Aging Research, Extramural Research Programs in the Neurosciences and Neurological Disorders and Vision Research.
Other grant recipients in Albany
- NYS Department of Health
- New York State Education Department
- New York State Office of Temporary & Disability Assistance
- New York State Division of Homeland Security & Emergency Services
- Department of Transportation New York
- Department of Labor New York
- Department of Environmental Conservation New York
- Health Research, Inc.
Largest federal grant recipients in New York · Federal grants in New York